Wayne G. Shreffler
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Division Chief
Also affiliated: Broad Institute (2019–2025); Boston University (2015); Northwestern University (2010); University of North Carolina at Chapel Hill (2022); Boston Children's Hospital (2019); Center for Infectious Disease Research (1992–1993); Mount Sinai Hospital (2004–2012); Children's Hospital of Philadelphia (2021); Harvard University (2011–2026); Johns Hopkins University (2024); Duke University (2004); Hebrew University of Jerusalem (2021–2026); Aarhus University (2003); Sinai Hospital (2007–2021); Harvard University Press (2011–2022); NYU Langone Health (1997); Massachusetts General Hospital (2010–2026); Mount Sinai Medical Center (2004–2011); Children's Hospital Colorado (2021); ENT and Allergy (2004–2025); MaineGeneral Medical Center (2019–2024); Marion General Hospital (2019–2023); Instituto de Urologia e Nefrologia (1994); National Institute of Allergy and Infectious Diseases (2024); Food Allergy Research and Education (2020); IDEX Corporation (United States) (1992); Cancer Genetics (United States) (1993); New York University (1995–1997); Massachusetts Institute of Technology (2019–2020); Charité - Universitätsmedizin Berlin (2004); University of Colorado Denver (2021); Icahn School of Medicine at Mount Sinai (2005–2012)
Faculty Researcher
Biomedical Subjects
Links
Biography and Research Information
Metrics
- h-index: 60
- Publications: 353
- Citations: 13,226
Selected Publications
-
Microbial metabolism of food allergens determines the severity of IgE-mediated anaphylaxis (2026)
-
Management of Gastrointestinal Symptoms During Oral Immunotherapy: Guidance from OUtMATCH Investigators (2026)
-
Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies (2025)
-
Multiomics approach to evaluating personalized biomarkers of allergen immunotherapy (2025)
-
Germline-encoded recognition of peanut underlies development of convergent antibodies in humans (2025)
-
Introduction of allergenic foods after treatment with omalizumab (2025)
-
Biomarker-driven drug development for allergic diseases and asthma: An FDA public workshop (2025)
-
Dietary plant diversity predicts early life microbiome maturation (2025)
-
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study) (2025)
-
Moving Beyond Desensitization to Tolerance in Food Allergy (2025)
-
Microbial metabolism of food allergens determines the severity of IgE-mediated anaphylaxis (2025)
-
First-in-human VLP Peanut Vaccine Candidate: Safety and Tolerability Data from on-going Phase I/IIa Clinical Trial (2025)
-
Treatment of Multi-Food Allergy with Omalizumab Compared to Omalizumab-Facilitated Multi-Allergen OIT (2025)
-
A molecular basis for milk allergen immune recognition in eosinophilic esophagitis (2025)
-
Interferon-γ Signaling in Eosinophilic Esophagitis Affects Epithelial Barrier Function and Programmed Cell Death (2025)